Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study

被引:12
作者
Le Roux, Marc-Kevin [1 ,2 ,3 ]
Graillon, Nicolas [1 ,2 ]
Guyot, Laurent [1 ,2 ]
Taieb, David [2 ,4 ]
Galli, Philippe [1 ,2 ]
Godio-Raboutet, Yves [3 ]
Chossegros, Cyrille [1 ,2 ]
Foletti, Jean-Marc [1 ,2 ,3 ]
机构
[1] CHU Conception, AP HM, Dept Maxillofacial Surg & Stomatol Pr Chossegros, Marseille, France
[2] Aix Marseille Univ, IFSTTAR, Marseille, France
[3] Aix Marseille Univ, LBA, IFSTTAR, Marseille, France
[4] CHU Timone, AP HM, Dept Nucl Med, Marseille, France
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2020年 / 42卷 / 11期
关键词
radioiodine therapy; salivary glands; sialadenitis; thyroid cancer; xerostomia; QUALITY-OF-LIFE; SWEDISH POPULATION; GLAND DYSFUNCTION; IODINE THERAPY; NASAL SYMPTOMS; I-131; THERAPY; CANCER; XEROSTOMIA; SCINTIGRAPHY; GUIDELINES;
D O I
10.1002/hed.26359
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Although many studies focus on short-term side effects of radioiodine therapy, almost none studied long-term side effects. We assessed radioiodine long-term salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma and compared it to short-term morbidity within the same population. Methods A standardized self-administrated questionnaire was submitted in 2019 by patients treated with radioiodine between January 2011 and December 2012. These patients had already answered the same questionnaire 6 years before. Results Our study showed a significant reduction for salivary side effects: discomfort in submandibular or parotid area, swelling, pain, a bad or salty taste in the mouth, allowing to get back to a "normal" diet. Conclusions Our study suggests that a significant rate of patients will recover from I(131)therapy salivary side effects. As almost 30% of these remissions happened during our late stage follow-up, we highlight the necessity of a long-term follow-up in these patients.
引用
收藏
页码:3133 / 3140
页数:8
相关论文
共 53 条
[1]   Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer [J].
Albano, Domenico ;
Bertagna, Francesco ;
Panarotto, Maria Beatrice ;
Giubbini, Raffaele .
PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
[2]  
ALBRECHT HH, 1976, FORTSCHR RONTG NEUEN, V125, P546
[3]   LATE SIDE EFFECTS OF RADIOACTIVE IODINE ON SALIVARY GLAND FUNCTION IN PATIENTS WITH THYROID CANCER [J].
Almeida, Juliana Pereira ;
Sanabria, Alvaro Enrique ;
Pereira Lima, Eduardo Nobrega ;
Kowalski, Luiz Paulo .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (05) :686-690
[4]   Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer [J].
An, Young-Sil ;
Yoon, Joon-Kee ;
Lee, Su Jin ;
Song, Hee-Sung ;
Yoon, Seok-Ho ;
Jo, Kyung-Sook .
ANNALS OF NUCLEAR MEDICINE, 2013, 27 (04) :386-391
[5]   Xerostomia in geriatric patients: a burgeoning global concern [J].
Anil, Sukumaran ;
Vellappally, Sajith ;
Hashem, Mohamed ;
Preethanath, Reghunathan S. ;
Patil, Shankargouda ;
Samaranayake, Lakshman P. .
JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY, 2016, 7 (01) :5-12
[6]   Age-related changes in human sublingual glands: a post mortem study [J].
Azevedo, LR ;
Damante, JH ;
Lara, VS ;
Lauris, JRP .
ARCHIVES OF ORAL BIOLOGY, 2005, 50 (06) :565-574
[7]   Utility of two oral health-related quality-of-life measures in patients with xerostomia [J].
Baker, Sarah R. ;
Pankhurst, Caroline L. ;
Robinson, Peter G. .
COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 2006, 34 (05) :351-362
[8]   Cost-effectiveness of follow-up contact for a postal survey: a randomised controlled trial [J].
Breen, Courtney L. ;
Shakeshaft, Anthony P. ;
Doran, Christopher M. ;
Sanson-Fisher, Rob W. ;
Mattick, Richard P. .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2010, 34 (05) :508-512
[9]   Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment [J].
Caglar, M ;
Tuncel, M ;
Alpar, R .
CLINICAL NUCLEAR MEDICINE, 2002, 27 (11) :767-771
[10]   Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology [J].
Chung, June-Key ;
Cheon, Gi Jeong .
ENDOCRINOLOGY AND METABOLISM, 2014, 29 (03) :233-239